Company Filing History:
1 out of 363 
1 out of 61 
Years Active: 2004-2022
Title: Celebrating the Innovations of Marc Karel Jozef Francois
Introduction: Marc Karel Jozef Francois is an accomplished inventor based in Kapellen, Belgium. With a focus on pharmaceutical innovations, he holds two patents that reflect his expertise in advancing treatments for significant health challenges, particularly in the field of HIV prevention.
Latest Patents: François' recent patents showcase his commitment to improving patient care. His first noteworthy invention is titled "Aqueous suspensions of TMC278." This patent covers pharmaceutical compositions designed for intramuscular or subcutaneous injection, utilizing micro- or nanoparticles of the NNRTI compound TMC278. These compositions aim to enhance the treatment and prophylaxis of HIV infection, demonstrating François' dedication to impactful pharmaceutical advancements.
His second patent, "Taste masked liquid pharmaceutical compositions," addresses a common challenge in medication – palatability. This invention comprises a liquid pharmaceutical composition that includes a taste masking effective amount of an artificial sweetener, facilitating easier ingestion of pharmaceutically active agents for patients.
Career Highlights: Marc Karel Jozef Francois has made significant contributions to the pharmaceutical industry. He has worked with reputable organizations, including Ortho-McNeil Pharmaceutical Corporation and Janssen Sciences Ireland Unlimited Company. These positions allowed him to leverage his innovative spirit and scientific knowledge in developing new medications and treatment strategies.
Collaborations: Throughout his career, François has collaborated with esteemed professionals, including Stephen Ulrich and Karen R Zimm. These partnerships have likely contributed to the successful development and implementation of his inventive ideas.
Conclusion: Marc Karel Jozef Francois stands out as an influential inventor in the realm of pharmaceuticals. His patents not only symbolize his innovative spirit but also reflect his commitment to enhancing patient care and addressing significant healthcare challenges, particularly in relation to HIV. As he continues to push the boundaries of pharmaceutical science, François serves as an inspiring figure for current and future inventors.